XML 47 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Common Stock
Class A Common Stock
Additional Paid-In Capital
Accumulated other comprehensive loss
Accumulated Deficit
Series A Preferred Stock
Series B Preferred Stock
Total
Beginning Balance (in shares) at Dec. 31, 2019       4,950,129            
Beginning Balance at Dec. 31, 2019       $ 4,950 $ 2,164,471   $ (8,697,742)     $ (6,528,321)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation expense         1,086,769         1,086,769
Net loss             (17,039,898)     (17,039,898)
Ending Balance at Dec. 31, 2020       $ 4,950 3,251,240   (25,737,640)     (22,481,450)
Ending Balance (in shares) at Dec. 31, 2020       4,950,129            
Beginning Balance at Dec. 31, 2019 $ 16,611,832   $ 16,611,832              
Beginning Balance (in shares) at Dec. 31, 2019 1,966,043             1,966,043    
Increase (Decrease) in Temporary Equity [Roll Forward]                    
Issuance of convertible preferred stock, net of issuance costs $ 4,508,108 $ 36,983,910 $ 36,983,910              
Issuance of convertible preferred stock, net of issuance costs (in shares) 529,890 3,619,292 4,508,108              
Ending Balance at Dec. 31, 2020 $ 21,119,940 $ 36,983,910 $ 58,103,850         $ 21,119,940 $ 36,983,910 58,103,850
Ending Balance (in shares) at Dec. 31, 2020 2,495,933 3,619,292           2,495,933 3,619,292  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options       $ 118 354,316         $ 354,434
Issuance of common stock upon exercise of stock options (in shares)       117,846           117,847
Issuance of common stock upon exercise of warrants       $ 308 926,817         $ 927,125
Issuance of common stock upon exercise of warrants (in shares)       308,308            
Conversion of Preferred Stock into common stock $ (21,119,940) $ (61,772,761) (82,892,701) $ 11,939 82,880,762         82,892,701
Conversion of Preferred Stock into common stock (in shares) (2,495,933) (6,032,145)   11,939,281            
Issuance of common stock upon initial public offering, net of issuance costs       $ 8,625 118,185,808         118,194,433
Issuance of common stock upon initial public offering, net of issuance costs (in shares)       8,625,000            
Issuance of common stock for acquisition       $ 380 7,874,620         7,875,000
Issuance of common stock for acquisition, shares       379,635            
Stock-based compensation expense         1,802,623         1,802,623
Net loss             (33,535,748)     (33,535,748)
Other comprehensive loss           $ (49,009)       (49,009)
Ending Balance at Dec. 31, 2021       $ 26,320 $ 215,276,186 $ (49,009) $ (59,273,388)     $ 155,980,109
Ending Balance (in shares) at Dec. 31, 2021       26,320,199            
Increase (Decrease) in Temporary Equity [Roll Forward]                    
Issuance of convertible preferred stock, net of issuance costs   $ 24,788,851 $ 24,788,851              
Issuance of convertible preferred stock, net of issuance costs (in shares)   2,412,853                
Ending Balance (in shares) at Dec. 31, 2021               0 0